These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 30367510)

  • 1. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.
    Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD
    Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells.
    Li W; Dong Y; Zhang B; Kang Y; Yang X; Wang H
    Biomed Pharmacother; 2016 Jul; 81():1-6. PubMed ID: 27261570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
    Jiang S; Liu X; Li D; Yan M; Ju C; Sun J; Jiang F
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818797587. PubMed ID: 30198403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEBP4 enhanced HCC827 cell proliferation and invasion ability and inhibited apoptosis.
    Yu G; Shen Z; Chen G; Teng X; Hu Y; Huang B
    Tumour Biol; 2013 Feb; 34(1):91-8. PubMed ID: 22983920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.
    Williamson AJ; Doscas ME; Ye J; Heiden KB; Xing M; Li Y; Prinz RA; Xu X
    Oncotarget; 2016 Mar; 7(9):10472-85. PubMed ID: 26859575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3 downregulation in NSCLC mediates epithelial-mesenchymal transition via NF-κB signaling.
    Wang X; Liu Y; Dai L; Liu Q; Jia L; Wang H; An L; Jing X; Liu M; Li P; Cheng Z
    Oncol Rep; 2016 Oct; 36(4):2282-8. PubMed ID: 27574108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
    Chen Y; Yang S; Zhou H; Su D
    Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM38 suppresses migration, invasion, metastasis, and proliferation in non-small cell lung cancer (NSCLC) via regulating the AMPK/NF-κB/NLRP3 pathway.
    Zhang K; Lin G; Nie Z; Jin S; Bing X; Li Z; Li M
    Mol Cell Biochem; 2024 Aug; 479(8):2069-2079. PubMed ID: 37566200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer.
    Yang F; Shao C; Wei K; Jing X; Qin Z; Shi Y; Shu Y; Shen H
    J Cell Physiol; 2019 Dec; 234(12):23596-23607. PubMed ID: 31236953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway.
    Wang TP; Hsu SH; Feng HC; Huang RF
    Carcinogenesis; 2012 Jun; 33(6):1158-68. PubMed ID: 22461522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEBP4 gene expression and its significance in invasion and metastasis of non-small cell lung cancer.
    Yu GP; Huang B; Chen GQ; Wu S; Ji Y; Shen ZY
    Tumour Biol; 2012 Feb; 33(1):223-8. PubMed ID: 22076923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer.
    Qiu X; Guan X; Liu W; Zhang Y
    Oncol Rep; 2017 Nov; 38(5):3103-3113. PubMed ID: 29048640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
    Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
    Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.